HelloMD expands white-label telehealth services for Licensed Producers and Clinics to better serve the medical cannabis marke...
October 29 2018 - 06:30AM
HelloMD, a leading online cannabis telehealth company, today
announces expansion of its white-label services for Licensed
Producers and brick-and-mortar clinics, to better serve the
Canadian medical cannabis market.
The company’s white-labeled patient consult and support services
offer Licensed Producers and brick-and-mortar cannabis clinics an
opportunity to rapidly expand their patient populations while
adding online solutions to better serve the fast growing
wellness-oriented cannabis consumer segment.
Many Canadians seeking medical cannabis have physical
limitations, live in areas far from the nearest clinic, or simply
prefer the discretion and convenience implicit in virtual consults.
HelloMD partners can offer their patients branded, online access to
healthcare professionals from the comfort of their preferred
location, seven days a week. The HelloMD platform has conducted
more than 100,000 online medical cannabis consults and been
deployed by 100’s of partners.
With zero capital outlay, and in as little as one day, HelloMD
white-label partners can launch branded versions of one or more
turnkey services:
- 100% Online Doctor Consultations.
HelloMD partner patients experience the convenience and privacy of
talking to a licensed practitioner from the comfort of wherever
they choose, and interact in an online environment that reflects
the partner’s brand. All practitioners are recruited, trained and
managed by HelloMD. Patient documents are securely shared with
partners via API or accessed via a partner portal.
- Education & Registration
Services. Following the online consultation, a
patient can engage, via video-chat, with a HelloMD patient services
team member for help with licensed producer selection and
registration. Alternatively, the partner can choose to have the
patient returned to them immediately following the practitioner
consult.
- Content Solutions. HelloMD can
produce ongoing, tailored educational content and make it available
within the partner’s branded patient portal. For partners reaching
first-time patients, this is an opportunity to extend their
position as a trusted source, without the heavy lifting of content
creation and management.
The Flowr Corporation (“Flowr”) (TSXV: FLWR) recently launched
HelloMD’s turnkey set of telehealth services. Patients and those
seeking a medical consultation can access the HelloMD service
through Flowr’s website https://flowr.ca/hellomd/.
“Flowr's partnership with HelloMD is part of our plan to offer a
premium service and product experience to our medical clients.
Flowr believes in easy access to cannabis for those who can benefit
from its medicinal qualities and making the HelloMD platform
available through our website gives clients convenient, discreet
access to healthcare professionals at the time and place of their
choosing. For some clients, this may be their only option to access
medical cannabis,” said Dr. Lyle Oberg, Flowr Chief Policy and
Medical Officer.
“HelloMD has always been a highly partner-centric company. We
focus our feature development, service scalability and level of
customer service on patients and the partners that serve them.
We’re excited to be working on Flowr and others seeking to expand
on their reach or the level of service they offer prospective
patients,” said Larry Lisser, HelloMD’s SVP of Business
Development.
To become a white label partner with HelloMD, please contact
Larry Lisser, SVP of Business Development HelloMD,
partners@hellomd.com
For Media Inquiries:
HelloMD: Garrett Repski, Project Manager, Marigold Marketing
& PR, 1-310-351-2383, garrett@marigoldpr.com
About HelloMD:
HelloMD is one of the largest online communities of medical
cannabis patients and experts, offering today's cannabis patient a
discreet, turnkey experience. At HelloMD.com medical cannabis
consumers can consult with a doctor via real-time video, and obtain
answers to questions from a network of doctors and experts.
Patients can also read the latest in cannabis research and news,
and engage with other patients about their experience. For more
information about HelloMD, or to join its growing member community,
visit www.hellomd.com or follow us on Facebook (@HelloMDcompany)
and Twitter (@HelloMD_com)
Forward-Looking Information:
This press release includes forward-looking information within
the meaning of Canadian securities laws, regarding Flowr and its
business, which may include, but is not limited to: Flowr’s belief
that all clients should have access to products they want and need;
the HelloMD program being a part of Flowr’s plans to offer a
premium service and experience; beliefs in easy access to cannabis;
the HelloMD platform giving clients convenient, discreet access to
healthcare professionals; HelloMD helping Flowr expand its reach or
level of service to patients or prospective patients; statements
relating to the partnership between Flowr and HelloMD; Flowr’s
ability to bring premium, quality products to the market; and other
factors. Often, but not always, forward-looking information can be
identified by the use of words such as “plans”, “is expected”,
“expects”, “scheduled”, “intends”, “contemplates”, “anticipates”,
“believes”, “proposes” or variations (including negative and
grammatical variations) of such words and phrases, or statements
that certain actions, events or results “may”, “could”, “would”,
“might” or “will” be taken, occur or be achieved. Such statements
are based on the current expectations of Flowr’s management and are
based on assumptions and subject to risks and uncertainties.
Although Flowr’s management believes that the assumptions
underlying these statements are reasonable, they may prove to be
incorrect. The forward-looking events and circumstances discussed
in this press release may not occur by certain specified dates or
at all and could differ materially as a result of known and unknown
risk factors and uncertainties affecting Flowr including risks
relating to: Flowr requiring additional financing from time to time
in order to continue its operations and such financing being
available when needed or on terms and conditions acceptable to
Flowr; new laws or regulations adversely affecting Flowr’s business
and results of operations; results of operation activities and
development of projects, project cost overruns or unanticipated
costs and expenses; the partnership with HelloMD not being
successful; the inability of Flowr’s products to be consistent,
convenient and/or high quality; the inability of Flowr to produce
and distribute premium, high quality and/or simple products; the
inability of HelloMD to assist Flowr in achieving a high level of
patient satisfaction; HelloMD not complying with laws, including
privacy laws; the HelloMD partnership not differentiating Flowr’s
cannabis offering and making a meaningful difference in patients’
lives; the inability of HelloMD to give patients the access
expected from this partnership; the partnership with HelloMD not
expanding Flowr’s reach or level of service it offers to patients
or prospective patients; Flowr’s sales program failing to provide
and deliver premium products, convenience and support; the
inability of the HelloMD partnership to offer a premium service and
experience and thus affecting Flowr’s sales strategy and sales; the
inability to supply the products described herein or any delay in
such supply; Flowr’s securities; the inability to generate cash
flows, revenues and/or stable margins; the inability to grow
organically; risks associated with the geographic markets in which
Flowr operates and/or distributes its products; risks associated
with fluctuations in exchange rates (including, without limitation,
fluctuations in currencies); risks associated with the use of
Flowr’s products to treat certain conditions; the cannabis industry
and the regulation thereof; failure to comply with applicable laws;
risks relating to partnership arrangements and possible failure to
realize the anticipated benefits of partnership arrangements,
including those discussed herein; product launches (including,
without limitation, unsuccessful product launches) or the inability
to launch products; the failure to obtain regulatory approvals;
economic factors, market conditions, risks associated with the
acquisition and/or launch of products and the equity and debt
markets generally; risks associated with growth and competition
(including, without limitation, with respect to Flowr’s products);
general economic and stock market conditions; risks and
uncertainties detailed from time to time in Flowr’s filings with
the Canadian Securities Administrators; and many other factors
beyond the control of Flowr. Although Flowr has attempted to
identify important factors that could cause actual actions, events
or results to differ materially from those described in
forward-looking information, there may be other factors that cause
actions, events or results to differ from those anticipated,
estimated or intended. No forward-looking information can be
guaranteed. Except as required by applicable securities laws,
forward-looking information speaks only as of the date on which it
is made and Flowr undertakes no obligation to publicly update or
revise any forward-looking information, whether as a result of new
information, future events, or otherwise.
The Flowr (TSXV:FLWR)
Historical Stock Chart
From Feb 2024 to Mar 2024
The Flowr (TSXV:FLWR)
Historical Stock Chart
From Mar 2023 to Mar 2024